ANDI & benign breast disorders

37,960 views 70 slides Apr 04, 2017
Slide 1
Slide 1 of 70
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46
Slide 47
47
Slide 48
48
Slide 49
49
Slide 50
50
Slide 51
51
Slide 52
52
Slide 53
53
Slide 54
54
Slide 55
55
Slide 56
56
Slide 57
57
Slide 58
58
Slide 59
59
Slide 60
60
Slide 61
61
Slide 62
62
Slide 63
63
Slide 64
64
Slide 65
65
Slide 66
66
Slide 67
67
Slide 68
68
Slide 69
69
Slide 70
70

About This Presentation

aberrations of normal development and involution and benign breast disorders - presentation for MBBS students


Slide Content

ANDI & Benign Breast disorders Dr. Dileep Ramesh Hoysal

ANDI ABERRATION OF NORMAL DEVELOPMENT AND INVOLUTION (ANDI) OF THE BREAST

Normal three phases of physiology of breast— (1) Lobular development; (2) Cyclical hormonal modifications; (3) Involution.

First coined by LE Hughes at Cardiff breast clinic in 1987 ANDI includes variety of benign breast disorders occurring at different periods of reproductive periods in females—early, matured and involution phase of reproductive age group.

Early reproductive age group (15-25 years) Normal lobule formation may cause aberration as fibroadenoma . >5 cm - Giant fibroadenoma as a diseased status. It is AND of a lobule. Normal stroma may develop juvenile hypertrophy as aberration and multiple fibroadenoma as diseased status.

Mature reproductive age group (25-40 years): Normal cyclical hormonal effects on glands and stroma get exaggerated by aberration causing generalised enlargement . Its disease is cyclical mastalgia with nodularity also called as fibrocystadenosis .

Involution age group (40-55 years): Lobular involution with microcysts , fibrosis, adenosis , apocrine metaplasia and eventual aberrations as macrocysts and cystic disease of breast. Macrocyst is an aberration of normal involution (ANI). Sclerosing adenosis is also a type of aberration.

Ductal involution Aberration - ductal dilatation and nipple discharge. Later Disease status develops with Periductal mastitis, Nonlactational breast abscess and Mammary duct fistula. Periductal fibrosis - partial nipple retraction. Epithelial changes leads into epithelial hyperplasia and atypia .

FIBROADENOMA Hyperplasia of a single lobule of the breast (AND). Most common benign tumour of the breast. Encapsulated tumour common in young females. Bilateral in 20% of cases. 20% are multiple.

Progression 30% of fibroadenomas may disappear or reduce in size in 2-4 years. 10 -15% will increase in size progressively. It does not occur after menopause unless women are on hormones.

Fibroadenoma Variants Juvenile fibroadenoma Occurs in adolescent girls. Even though it shows rapid growth with stromal and epithelial hyperplasia, it does not show any alteration in stromal epithelial balance or cellular atypia or periductal cellular concentration. Mimic phyllodes tumour .

2. Complex fibroadenoma It occurs in older age group. Having typical fibroadenoma with fibrocystic changes like apocrine metaplasia , cyst formation, sclerosing adenosis . 15% of proven fibroadenomas are complex. Occasionally it may turn into malignancy unlike usual fibroadenomas .

Pathological Types Intracanalicular : large and soft—mainly cellular. Stroma with distorted duct. Pericanalicular : small and hard—mainly fibrous. Stroma with normal duct

Clinical Features Painless swelling Smooth, firm, nontender , well- localised and Moves freely within the breast tissue ( mouse in the breast ).

Investigations Mammography (well- localised smooth regular shadow). FNAC. Ultrasound (to confirm solid nature).

Treatment Fibroadenoma which is small (< 3 cm)/single/age < 30 years can be left alone with regular follow-up with USG at 6 monthly interval. Indications for surgery are: Size > 3 cm. Multiple. Giant type. Recurrence. Cosmesis . Complex type.

Early Reproductive Period(15-25yrs)

PHYLLOIDES TUMOR Aka Cystosarcoma Phylloides Or Serocystic Disease Of Brodie This Is A Giant Fibroadenoma Which Shows A Wide Spectrum Of Activity From A Benign Condition (85%) To Locally Aggressive To Metastatic Tumor (15%)

Gross : Large, Capsulated, Cystic Changes Cut Curface : Soft, Cystic Spaces Microscopy: Cystic Spaces With Leaf Like Projections Hence Called “ Phylloides ”

CLINICAL FEATURES 30-50yrs Unilateral Grows rapidly to attain large size Bosselated surface with necrosis of skin Swelling is warm, not fixed to skin or chest wall

INVESTIGATIONS ULTRASOUND FNAC CHEST XRAY

TREATMENT Excision Total Mastectomy If Malignant

Mature Reproductive Period (25-40yrs)

Cyclical Mastalgia With Nodularity Aka Fibrocystadenosis / Fibrocystic Disease Of Breast/ Mammary Dysplasia Estrogen Dependant

BLUEDOME CYST OF BLOODGOOD One Of The Cyst May Get Enlarged And Become Clinically Palpable Non Tender, Fluctuant, Transilluminant With Thin Bluish Capsule

Initially Aspirated Surgical Excision Done If Recurs/ Persists/ Blood Stained/ Residual Lump Remains Multiple Small Cysts – Schimmelbusch’s Disease

FIBROCYSTADENOSIS

CLINICAL FEATURES B/L, Diffuse, Painful, Granular Swelling Better Felt With Palpating Fingers Pain And Tenderness More Just Prior To Menstruatuion Subsides During Pregnancy/ Lactation/ After Menopause

INVESTIGATIONS FNAC- EPITHELIOSIS (PREMALIGNANT) USG MAMMOGRAPHY

TREATMENT CONSERVATIVE Reassurance Oil Of Evening Primrose: Gamolenic Acid NSAIDS Vit E And B6 Bromocriptine - Prolactin Inhibitor Tamoxifen - Estrogen Antagonist Danozol - Antigonadotrohin Agent

SURGERY Excision Of Cyst/ Diseased Tissue D/D: Tietze’s Disease Costochondritis Of Second Costal Cartilage

Involution (35-55 yrs)

SCLEROSING ADENOSIS 30-50yrs Present With Breast Lump Or Mastalgia Smooth, Relatively Mobile Mass Mimic Carcinoma Clinically, Radiologically And Histologically

DUCT ECTASIA Dilatation Of Lactiferous Duct Due To Muscular Relaxation Of Duct Wall With Periductal Matitis Aka Plasma Cell Mastitis Many Ducts Involved

CLINICAL FEATURES GREENISH NIPPLE DISCHARGE TENDER INDURATED MASS UNDER THE AREOLAR EVENTUALLY FORMS ABSCESS AND FISTULA LATER STAGE- RETRACTION OF NIPPLE

COMMON IN SMOKERS- IN RELATION TO ARTERIAL PATHOLOGY B/L AND MULTIFOCAL D/D –CARCINOMA BREAST

TREATMENT STOP SMOKING CONE EXCISION OF INVOLVED MAJOR DUCTS- HADFIELD OPERATION ANTIBIOTICS

MASTITIS TYPES: (1) SUBAREOLAR MASTITIS- INFECTED GLAND OF MONTGOMERY (2) INTRAMAMMARY MASTITIS -LACTATING ABSCESS - NON LACTATING ABSCESS (3) RETROMAMMARY MASTITIS- TB OF INTERCOSTAL LYMPH NODES

MASTITIS

BREAST ABSCESS

ANTIBIOMA

PREVIOUS HISTORY OF MASTITIS D/D- CARCINOMA AS IF HARD AND FIXED TO BREAST TISSUE EXCISION

OTHER BENIGN BREAST CONDITIONS GALACTOCOELE -SEEN IN LACTATING WOMEN -RETENSION CYST IN SUBAREOLAR REGION -BLOCK OF LACTIFEROUS DUCT -MASSIVE ENLARGEMENT OF LACTIFEROUS SINUS

PRESENT AS LARGE, SMOOTH, SOFT, FLUCTUANT LUMP CAN GET INFECTED EXCISION

TRAUMATIC FAT NECROSIS DIRECT OR INDIRECT TRAUMA SMOOTH, HARD, NON TENDER, NOT ADHERENT EXCISION

DUCT PAPILLOMA COMMONEST CAUSE OF BLOODY NIPPLE DISCHARGE USUALLY SINGLE FROM A SINGLE LACTIFEROUS DUCT IF MUTIPLE – CAN BE PREMALIGNANT

INVESTIGATION- INJECT CONTRAST INTO DUCT (DUCTOGRAM) MICRODOCHECTOMY : PROBED LACTIFEROUS DUCT IS OPENED AND THE PAPILLOMA EXCISED USING TENNIS RAQUET INCISION

GYNECOMASTIA HYPERTROPHY OF MALE BREAST DUE TO INCREASE IN DUCTAL AND CONNECTIVE TISSUE ELEMENT OFTEN ATTAINING FEATURES OF FEMALE BREAST U/L OR B/L

CAUSES IDIOPATHIC DRUGS: SPIRONOLACTONE. INH, PHENOTHIAZIDES, DIGITALIS LIVER FAILURE AND LIVER DISEASE LEPROSY TEROTOMA TESTIS ADRENAL AND PITUITARY DISEASE ECTOPIC HORMONE PRODUCTION KLINEFELTERS

SMALL , WELL LOCALIZED, FIRM SWELLING BELOW THE ARELOAR WHICH IS PAINFUL WHEN SYMPTOMATIC- EXCISED

THANK YOU